AI breakthrough predicts 17 diseases using multi-omics data from half a million people

A new study has developed a way to predict 17 different diseases by combining multiple biological data types. Published in Nature Communications, the research uses advanced computing to analyse complex health information. The findings could lead to earlier diagnoses and better patient care. The project was led by Du, J., Zhou, M., Wang, H., and their team. They drew data from the UK Biobank, which includes records from half a million people. By integrating genomics, transcriptomics, proteomics, metabolomics, and epigenomics—known as multi-omics—they aimed to uncover patterns linked to disease development.

Handling such vast and varied data posed challenges. Issues like missing values, inconsistent formats, and batch effects were tackled with strict preprocessing and smart feature selection. The team then applied machine learning and cutting-edge algorithms to process the multi-dimensional datasets. The result was a model capable of forecasting a wide range of conditions. These include cardiovascular, neurological, metabolic, and autoimmune diseases. Beyond prediction, the study also revealed shared molecular pathways, offering clues for new treatments that target multiple diseases at once. The researchers highlighted practical concerns as well. Data privacy and patient involvement were key considerations in their approach.

This method could transform healthcare by enabling earlier interventions and lowering treatment costs. The integration of multi-omics data provides a clearer picture of disease risks and mechanisms. The team’s work opens doors for further research into multi-targeted therapies.